PATRICK WHEAT: Open Payments
NPI 1003897208 · NATCHITOCHES, LA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$333 in 14 payments from 8 companies in 2025. Trend: 2023 $0 · 2024 $276 · 2025 $333
Food & beverage: $333
| Company | Payments | Amount |
|---|---|---|
| Supernus Pharmaceuticals, Inc. | 2 | $83 |
| E.R. Squibb & Sons, L.L.C. | 3 | $61 |
| Neurocrine BioSciences, Inc. | 2 | $51 |
| Boehringer Ingelheim Pharmaceuticals, Inc. | 2 | $47 |
| Alkermes, Inc. | 2 | $37 |
| Axsome Therapeutics, Inc. | 1 | $23 |
| Braeburn Inc. | 1 | $18 |
| Otsuka America Pharmaceutical, Inc. | 1 | $14 |
Products named: Qelbree, COBENFY, INGREZZA, ARISTADA, Auvelity, BRIXADI, ABILIFY ASIMTUFII.
Industry payments across LA — which companies pay providers there.
